111In-DOTA-3A3

N/A

Report date: 2025/11/10 17:58:30

Base Information

Drug Name111In-DOTA-3A3

Drug Alias NameHER3-targeting affibody (Uppsala University)111In-Z08698111In-ZHER3-ABD-ZHER3

ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyRadiation-emitting products > Nuclides > Indium > 111In +[5]

Mechanisms of ActionSerum albumin modulatorsReceptor tyrosine-protein kinase erbB-3 modulators

TargetsSerum albuminReceptor tyrosine-protein kinase erbB-3

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySweden

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUppsala University

China Registration ClassN/A

Develop Information

Active CompaniesUppsala University

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A